Attovia Therapeutics, Inc. (ATTO) vs Avalo Therapeutics, Inc. (AVTX)
A side-by-side comparison of Attovia Therapeutics, Inc. and Avalo Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATTO
Attovia Therapeutics, Inc.
$17.71HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
AVTX
Avalo Therapeutics, Inc.
$13.93HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — ATTO vs AVTX
growth of $100 · dividends reinvested · last 1yATTO -17.8% (-17.8%/yr)AVTX -21.2% (-21.2%/yr)ATTO compounded faster over this window
ATTO AVTX
ATTO vs AVTX: by the numbers
- •ATTO is the larger company ($762M vs $732M market cap).
- •Both run net losses; ATTO's is the smaller (-4490.89% vs -170055.93% net margin).
Metrics side by side
Valuation
| Metric | ATTO | AVTX |
|---|---|---|
| P/S ratio | N/A | 12406.37 |
| P/B ratio | N/A | 1.63 |
Profitability
| Metric | ATTO | AVTX |
|---|---|---|
| Gross margin | 40.44% | 100.00% |
| Operating margin | -4974.74% | -123601.69% |
| Net margin | -4490.89% | -170055.93% |
| ROE | -40.21% | -22.36% |
| ROIC | -42.83% | -19.45% |
Growth (annualized)
| Metric | ATTO | AVTX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -60.88% |
| Total return CAGR (5Y) | N/A | -70.04% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.